메뉴 건너뛰기




Volumn 39, Issue 2, 2005, Pages 357-360

Verapamil toxicity resulting from a probable interaction with telithromycin

Author keywords

Interaction; Telithromycin; Verapamil

Indexed keywords

DOPAMINE; HYPERTENSIVE FACTOR; NORADRENALIN; TELITHROMYCIN; VERAPAMIL;

EID: 12844273505     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E496     Document Type: Article
Times cited : (26)

References (19)
  • 2
    • 3242805224 scopus 로고    scopus 로고
    • Activity of telithromycin against key pathogens associated with community-acquired respiratory tract infections
    • Low DE, Felmingham D, Brown SD, Rangaraju M, Nusrat R. Activity of telithromycin against key pathogens associated with community-acquired respiratory tract infections. J Infect 2004;49:115-25.
    • (2004) J Infect , vol.49 , pp. 115-125
    • Low, D.E.1    Felmingham, D.2    Brown, S.D.3    Rangaraju, M.4    Nusrat, R.5
  • 3
    • 0036194907 scopus 로고    scopus 로고
    • Telithromycin: The first of the ketolides
    • DOI 10.1345/aph.1A038
    • Shain CS, Amsden GW. Telithromycin: the first of the ketolides. Ann Pharmacother 2002;36:452-64. DOI 10.1345/aph.1A038
    • (2002) Ann Pharmacother , vol.36 , pp. 452-464
    • Shain, C.S.1    Amsden, G.W.2
  • 4
    • 0042090159 scopus 로고    scopus 로고
    • Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment
    • Cantallobe C, Bhargava V, Sultan E, Vacheron F, Batista I, Montay G. Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment. Int J Antimicrob Agents 2003;22:112-21.
    • (2003) Int J Antimicrob Agents , vol.22 , pp. 112-121
    • Cantallobe, C.1    Bhargava, V.2    Sultan, E.3    Vacheron, F.4    Batista, I.5    Montay, G.6
  • 5
    • 0042358739 scopus 로고    scopus 로고
    • Ketolides: A new class of antibacterial agents for treatment of community-acquired respiratory tract infections in the primary care setting
    • Clark JP, Langston E. Ketolides: a new class of antibacterial agents for treatment of community-acquired respiratory tract infections in the primary care setting. Mayo Clin Proc 2003;78:1113-24.
    • (2003) Mayo Clin Proc , vol.78 , pp. 1113-1124
    • Clark, J.P.1    Langston, E.2
  • 7
    • 0029621846 scopus 로고
    • Massive overdose of sustained-release verapamil: A case report and review of the literature
    • Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive overdose of sustained-release verapamil: a case report and review of the literature. Am J Med Sci 1995;310:258-63.
    • (1995) Am J Med Sci , vol.310 , pp. 258-263
    • Ashraf, M.1    Chaudhary, K.2    Nelson, J.3    Thompson, W.4
  • 8
    • 0007548201 scopus 로고
    • Antihypertensive agents
    • Goldfrank LR, Flomenbaum NE, Lewin NA, eds. Norwalk, CT: Appleton & Lange
    • Lewin NA. Antihypertensive agents. In: Goldfrank LR, Flomenbaum NE, Lewin NA, eds. Goldfrank's toxicologic emergencies. 5th ed. Norwalk, CT: Appleton & Lange, 1994:704-8.
    • (1994) Goldfrank's Toxicologic Emergencies. 5th Ed. , pp. 704-708
    • Lewin, N.A.1
  • 9
    • 0032897280 scopus 로고    scopus 로고
    • Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil
    • Tracy TS, Korzekwa KR, Gonzalez FJ, Wainer IW. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. Br J Clin Pharmacol 1999;47:545-52.
    • (1999) Br J Clin Pharmacol , vol.47 , pp. 545-552
    • Tracy, T.S.1    Korzekwa, K.R.2    Gonzalez, F.J.3    Wainer, I.W.4
  • 10
  • 11
    • 0043124614 scopus 로고    scopus 로고
    • Drug interactions with angiotensin receptor blockers: A comparison with other antihypertensives
    • Unger T, Kaschina E. Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives. Drug Saf 2003;26:707-20.
    • (2003) Drug Saf , vol.26 , pp. 707-720
    • Unger, T.1    Kaschina, E.2
  • 12
    • 0032420063 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of oxaprozin
    • Davies NM. Clinical pharmacokinetics of oxaprozin. Clin Pharmacokinet 1998;35:425-36.
    • (1998) Clin Pharmacokinet , vol.35 , pp. 425-436
    • Davies, N.M.1
  • 13
    • 0030783057 scopus 로고    scopus 로고
    • Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans
    • Chiba M, Xu X, Nishime JA, Balani SK, Lin JH. Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans. Drug Metab Dispos 1997;25:1022-31.
    • (1997) Drug Metab Dispos , vol.25 , pp. 1022-1031
    • Chiba, M.1    Xu, X.2    Nishime, J.A.3    Balani, S.K.4    Lin, J.H.5
  • 14
    • 0033924849 scopus 로고    scopus 로고
    • Drug interactions with cisapride: Clinical implications
    • Michalets EL, Williams CR. Drug interactions with cisapride: clinical implications. Clin Pharmacokinet 2000;39:49-75.
    • (2000) Clin Pharmacokinet , vol.39 , pp. 49-75
    • Michalets, E.L.1    Williams, C.R.2
  • 16
    • 0037342872 scopus 로고    scopus 로고
    • Drugs of the 21st century: Telithromycin (HMR 3647) - The first ketolide
    • Ackermann G, Rodloff AC. Drugs of the 21st century: telithromycin (HMR 3647) - the first ketolide. J Antimicrob Chemother 2003;51:497-511.
    • (2003) J Antimicrob Chemother , vol.51 , pp. 497-511
    • Ackermann, G.1    Rodloff, A.C.2
  • 17
    • 1242272026 scopus 로고    scopus 로고
    • Efficacy and tolerability of once-daily telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults
    • Dunbar LM, Hassman J, Tellier G. Efficacy and tolerability of once-daily telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults. Clin Ther 2004;26:48-62.
    • (2004) Clin Ther , vol.26 , pp. 48-62
    • Dunbar, L.M.1    Hassman, J.2    Tellier, G.3
  • 18
    • 0034851464 scopus 로고    scopus 로고
    • Clinical-pharmacological strategies to assess drug interaction potential during drug development
    • Kuhlmann J, Muck W. Clinical-pharmacological strategies to assess drug interaction potential during drug development. Drug Saf 2001;24:715-25.
    • (2001) Drug Saf , vol.24 , pp. 715-725
    • Kuhlmann, J.1    Muck, W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.